WallStSmart
CRL

Charles River Laboratories

NYSE: CRL · HEALTHCARE · DIAGNOSTICS & RESEARCH

$166.97
+1.91% today

Updated 2026-04-30

Market cap
$8.23B
P/E ratio
P/S ratio
2.05x
EPS (TTM)
$-2.90
Dividend yield
52W range
$114 – $229
Volume
0.9M

Charles River Laboratories (CRL) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$164.37M$284.25M$279.95M$225.04M$169.01M$205.28M$207.90M$207.14M$251.05M$286.36M$298.32M$316.26M$441.14M$480.94M$546.58M$760.80M$619.64M$683.90M$734.58M$737.65M
Capital expenditures$181.75M$227.04M$197.08M$80.01M$42.86M$49.14M$47.53M$39.15M$56.92M$63.25M$55.29M$82.43M$140.05M$140.51M$166.56M$228.77M$324.73M$318.53M$232.97M$219.15M
Depreciation
Stock-based comp$21.09M$21.09M$24.33M$23.81M$25.53M$21.71M$21.86M$24.54M$31.04M$40.12M$43.64M$44.00M$47.35M$57.27M$56.34M$71.47M$73.62M$72.05M$69.89M$71.08M
Free cash flow$-17.38M$57.21M$82.87M$145.03M$126.15M$156.14M$160.37M$167.99M$194.13M$223.11M$243.03M$233.83M$301.09M$340.42M$380.01M$532.03M$294.91M$365.37M$501.61M$518.49M
Investing cash flow
Financing cash flow
Dividends paid$1.92M$1.92M$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$34.55M$46.59M$45.65M$25.60M
Share repurchases
Debt repayment
Net change in cash$-3.41M$-110.25M$40.78M$46.24M$4.10M$-42.08M$-321000.00$37.01M$44.20M$31.37M$-7.72M$-4.54M$-30.68M